We apologize if your country is not currently listed. Please feel free to contact us through our global page and we will do our best to assist you.
Böblingen, February 22, 2024 – Wörwag Pharma closed the 2023 financial year with an organic sales growth of 7.6 percent – despite the tense situation…
Böblingen, January 22, 2024 – With the renaming of the most recent investment Mauermann Arzneimittel GmbH & Co. KG, Wörwag Pharma is taking the next…
Böblingen, March 16, 2023 – The Böblingen-based pharmaceutical and family-owned company Wörwag Pharma closed the 2022 financial year with an increase…
Böblingen, February 17, 2022 – The Boeblingen-based family-owned company Wörwag Pharma invested in several strategic milestones in 2021 and…
In order to support science and research, Wörwag Pharma has awarded the 10th Fritz Wörwag Research Prize this year. The prize rewards new research…
Böblingen/Lódz – German pharmaceutical company Wörwag Pharma GmbH & Co. KG announces the acquisition of Sensilab, contract manufacturer and…